Genespire
Gene therapies developer for pediatric patients.
1
Funding Rounds
$52.0m
Money raised
Overview
Gene therapies developer for pediatric patients.
- Website:
- Business model: B2B
- Headquarters: Milan
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Genespire has raised a total of $52m in funding over 1 rounds.
Key Insights:
- Genespire Series B round, September 2024: $52m
Genespire Series B round, September 2024
$52m
Industries
Genespire is active in the following industries: